Differential Gag-Specific Polyfunctional T Cell Maturation Patterns in HIV-1 Elite Controllers
- Sara Ferrando-Martíneza,b,
- Joseph P. Casazzac,
- Manuel Lealb,
- Kawthar Machmachb,
- Ma Ángeles Muñoz-Fernándeza,
- Pompeyo Vicianad,
- Richard A. Koupc and
- Ezequiel Ruiz-Mateosb
- aLaboratory of Molecular Immuno-Biology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
- bLaboratory of Immunovirology, Infectious Diseases Service, Hospital Universitario Virgen del Rocío, Institute of Biomedicine of Sevilla (IBiS), Seville, Spain
- cImmunology Laboratory, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, USA
- dInfectious Diseases Service, Hospital Universitario Virgen del Rocío, Seville, Spain
ABSTRACT
A small fraction of HIV-infected individuals (<1%), referred to as elite controllers (EC), are able to maintain undetectable viral loads indefinitely without treatment. The role of the maturational phenotype of T cells in the control of HIV infection in these individuals is not well described. We compared the maturational and functional phenotypes of Gag-specific CD4 and CD8 T cells from EC, who maintain undetectable viral loads without treatment; relative controllers (RC), who maintain viral loads of <1,000 copies/ml without treatment; and noncontrollers (NC), who fail to control viral replication. EC maintained higher frequencies of HIV-specific CD4 T cells, less mature polyfunctional Gag-specific CD4 T cells (CD27+ CD57− CD45RO+), and Gag-specific polyfunctional CD4 T cells than those observed in NC. In EC, the frequency of polyfunctional Gag-specific CD8 T cells was higher than that observed in RC and NC. RC had a similar functional phenotype to that observed in NC, despite consistently lower viral loads. Finally, we found a direct correlation between the frequency of Gag-specific CD27+ CD57− CD45RO+ CD4+ T cells and the frequency of mature HIV-specific CD8 T cells. Altogether, our data suggest that immature Gag-specific interleukin-2 (IL-2)-producing CD4+ T cells may play an important role in spontaneous control of HIV viremia by effectively supporting HIV-specific CD8 T lymphocytes. This difference appears to differentiate EC from RC.
FOOTNOTES
- Received 7 December 2011.
- Accepted 10 January 2012.
- Address correspondence to Ezequiel Ruiz-Mateos, ezequiel.ruizmateos{at}gmail.com.
-
Published ahead of print 25 January 2012
- Copyright © 2012, American Society for Microbiology. All Rights Reserved.











